SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (399)1/29/2003 10:38:23 AM
From: Czechsinthemail  Read Replies (1) of 598
 
mopgcw, Thanks for the CC notes.

One small correction: I believe they forecast revenues of $20-25 million NOT including new additional revenues. They added that these revenues were pretty much in the bag. They also indicated that there was a lot of interest from potential partners and that they would be exploring partnering opportunities for individual drugs, preclinical candidates and perhaps entire programs (like oncogenes). They added that they expected to be able to establish partnerships on very favorable terms.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News